Paper26567992
Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion.
Ikeda A and 10 others. Intern Med, 2015. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion. Papers, record 26567992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26567992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Dissection | Major topic |
| Esophageal Neoplasms | Major topic |
| Esophagoscopy | Major topic |
| Esophagus | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Aged | |
| Chemoradiotherapy | |
| Combined Modality Therapy | |
| Female | |
| Humans | |
| Japan | |
| Male | |
| Middle Aged | |
| Mucous Membrane | |
| Neoplasm Staging | |
| Quality of Life | |
| Retrospective Studies | |
| Survival Rate | |
| Treatment Outcome |
Source PubMed
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42626576 | Endoscopic Submucosal Dissection and Chemoradiotherapy versus Esophagectomy for T1a-m3 or T1b Esophageal Squamous Cell Carcinoma: A Meta-analysis. | Endosc Int Open | 2026 | https://conductscience.org/library/papers/42626576 | PubMed |
| 42564051 | Comparative efficacy and outcomes of different treatments for pathologically high-risk superficial esophageal cancer: a systematic review and network meta-analysis. | Front Oncol | 2026 | https://conductscience.org/library/papers/42564051 | PubMed |
| 42488030 | Additional chemoradiotherapy versus esophagectomy for early esophageal cancer: an integrated analysis of reconstructed time-to-event data. | Ther Adv Gastroenterol | 2026 | https://conductscience.org/library/papers/42488030 | PubMed |
| 41943646 | Next step after endoscopic resection for superficial esophageal squamous cell carcinoma: metastatic risk assessment and management of non-curative resection cases. | Clin Endosc | 2026 | https://conductscience.org/library/papers/41943646 | PubMed |
| 41695917 | Predicting the magnitude of risk for non-curative endoscopic submucosal dissection in superficial esophageal cancer using explainable artificial intelligence. | World J Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/41695917 | PubMed |
| 41114901 | Outcomes of additional chemotherapy for esophageal squamous cell carcinoma following non-curative endoscopic submucosal dissection. | Int J Clin Oncol | 2025 | https://conductscience.org/library/papers/41114901 | PubMed |
| 40968731 | Long-term outcomes of additional surgical versus nonsurgical treatment after non-curative endoscopic resection for T1 superficial esophageal cancer. | Int J Surg | 2026 | https://conductscience.org/library/papers/40968731 | PubMed |
| 40646314 | Endoscopic Submucosal Dissection Followed by Chemoradiotherapy Versus Radiotherapy in Patients with Stage T1bN0M0 Esophageal Cancer. | J Gastrointest Cancer | 2025 | https://conductscience.org/library/papers/40646314 | PubMed |
| 40589630 | Additional chemoradiotherapy following endoscopic submucosal dissection in patients with esophageal squamous cell carcinoma: a narrative review. | Front Oncol | 2025 | https://conductscience.org/library/papers/40589630 | PubMed |
| 40002274 | Esophagectomy Versus Endoscopic Resection with Adjuvant Therapy for T1b/T2 Esophageal Cancer: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40002274 | PubMed |
| 39777993 | Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell Carcinoma. | Thorac Cancer | 2025 | https://conductscience.org/library/papers/39777993 | PubMed |
| 38386660 | A retrospective cohort study to observe the efficacy and safety of Endoscopic Submucosal Dissection (ESD) with adjuvant radiotherapy for T1a-MM/T1b-SM Esophageal Squamous Cell Carcinoma (ESCC). | PLoS One | 2024 | https://conductscience.org/library/papers/38386660 | PubMed |
| 37691683 | Long-term survival in esophagectomy for early-stage esophageal cancer versus endoscopic resection plus additional chemoradiotherapy: a systematic review and meta-analysis. | J Thorac Dis | 2023 | https://conductscience.org/library/papers/37691683 | PubMed |
| 36933136 | Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 1. | Esophagus | 2023 | https://conductscience.org/library/papers/36933136 | PubMed |
| 36765546 | Efficacy of Organ Preservation Strategy by Adjuvant Chemoradiotherapy after Non-Curative Endoscopic Resection for Superficial SCC: A Multicenter Western Study. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36765546 | PubMed |
| 36644141 | Additional endoscopic treatments for patients with positive lateral margins after endoscopic resection of early esophageal squamous cell carcinoma. | Oncol Lett | 2023 | https://conductscience.org/library/papers/36644141 | PubMed |
| 36445654 | Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma. | Dig Dis Sci | 2023 | https://conductscience.org/library/papers/36445654 | PubMed |
| 36401267 | Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes. | Radiat Oncol | 2022 | https://conductscience.org/library/papers/36401267 | PubMed |
| 36220991 | Therapeutic strategies following endoscopic submucosal dissection for T1a-MM/T1b-SM1 esophageal squamous cell carcinoma: comparisons of long-term outcomes with propensity score-matched analysis. | Surg Endosc | 2023 | https://conductscience.org/library/papers/36220991 | PubMed |
| 36205033 | Clinical models to predict lymph nodes metastasis and distant metastasis in newly diagnosed early esophageal cancer patients: A population-based study. | Cancer Med | 2023 | https://conductscience.org/library/papers/36205033 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26567992
GET https://conductscience.org/api/papers/v1/26567992/cited_by?page=2